COR

UBS Investment Research – Matria to acquire CorSolutions

UBS Investment Research – Matria to acquire CorSolutions

Transformational transaction - expect diversitures to follow The acquisition of CorSolutions (Cor), coupled with the expected divestiture of the company's Facet and German disease management business should bring MATR much closer to its goal of being a purely disease...

read more

Contact Us

Get in touch, we would like to hear from you!

Call by phone

(678) 294-4141

Follow Us

LinkedIn